Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

World-class Biomedical Research Centre to be in West London

11.12.2006
An international team of experts has judged the biomedical research conducted at The Hammersmith Hospitals NHS Trust, St Mary’s NHS Trust and Imperial College London to be amongst the very best in the country.

Health Secretary Patricia Hewitt announced last week (8 December) the creation of eleven Biomedical Research Centres (BRC) and awarded BRC status to the two hospitals in partnership with Imperial College. BRCs will be leaders in translating scientific research into benefits for patients. Imperial’s academic clinicians will work with their NHS colleagues to take research from the bench to the bedside, enabling the adoption of new technologies, techniques and treatments.

The award guarantees the partners research funding of £19.5 million per annum for the next five years, and makes the West London BRC the leading centre for the UK.

Trust Chief Executives Derek Smith and Julian Nettel, and Rector of Imperial College London Sir Richard Sykes said, “We are delighted to be recognised for the innovative research which is carried out through our partnership to advance healthcare and medical research around the world. Our research is at the forefront of biomedical invention with the primary goal of improving patient care.”

Awarding BRC status to the Trusts in academic partnership with Imperial is an endorsement of their intention to become the UK's first Academic Health Science Centre. (AHSC). The AHSC will be a healthcare organisation that integrates governance and management for service delivery, teaching and research, based on tried and tested models around the world. This concept represents a future that has captured the imagination and support of clinical leaders and senior management of all organisations and will enable West London to compete on a global stage.

The AHSC will be a magnet for investment and for clinical leaders who champion the creation and delivery of new diagnostic and treatment options to improve the lives and welfare of patients.

Staff, patients and local communities will be involved in designing and planning the AHSC as well as being formally consulted about it in 2007.

Between them the hospitals can already boast the best breast cancer survival rates; the best lung cancer survival rates; and the third and fourth fewest deaths during coronary artery by-pass operations. They have achieved this record by employing the very latest thinking, technology and treatments.

Imperial College is the UK’s leading clinical academic university with 140 clinical academic fellows and 53 clinical lecturers. It recently had its world-class reputation confirmed by the Times Higher Educational 2006 World University Rankings, which placed the university fourth in the world for biomedicine and ninth in the world overall.

Further endorsement was received in the Chancellor’s pre-budget statement this week (6 December). Gordon Brown announced that the government accepted the findings of a new report into UK Health Research funding, which included a statement of support for the AHSC model. The Cooksey report states: "Universities and Trusts might follow the US Academic Medical Centre model, as Imperial College and St. Mary's and Hammersmith NHS Trusts are doing with their plan to create the UK's first Academic Health Sciences Centre. This proposal, which promises to deliver greater integration of not only research strategies, but vital underpinning human resources and capital assets, should make for a more effective approach to health research and patient care at these institutions.”

Abigail Smith | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht 'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton

nachricht A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

Im Focus: Fast, convenient & standardized: New lab innovation for automated tissue engineering & drug

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.

MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...

Im Focus: Silencing bacteria

HZI researchers pave the way for new agents that render hospital pathogens mute

Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...

Im Focus: Artificial Enzymes for Hydrogen Conversion

Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.

Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

New quantum phenomena in graphene superlattices

19.09.2017 | Physics and Astronomy

A simple additive to improve film quality

19.09.2017 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>